Assessing patients’ risk of febrile neutropenia: is there a correlation between physician‐assessed risk and model‐predicted risk?

Publisher： John Wiley & Sons Inc

E-ISSN： 2045-7634|4|8|1153-1160

ISSN： 2045-7634

Source： Cancer Medicine, Vol.4, Iss.8, 2015-08, pp. : 1153-1160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors

By  

Cancer Medicine, Vol. 7, Iss. 2, 2018-02 ,pp. : 508-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone

By Mizuno Toshiro   Katsumata Noriyuki   Mukai Hirofumi   Shimizu Chikako   Ando Masashi   Watanabe Toru  

Supportive Care in Cancer, Vol. 15, Iss. 3, 2007-03 ,pp. : 287-291

Springer Publishing Company

Access to resources Recommend Favorite

A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia

By Lalami Y.   Paesmans M.  

Supportive Care in Cancer, Vol. 12, Iss. 10, 2004-10 ,pp. : 725-730

Springer Publishing Company

Access to resources Recommend Favorite

Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score

By Uys Almarie  

Supportive Care in Cancer, Vol. 12, Iss. 8, 2004-08 ,pp. : 555-560

Springer Publishing Company

Access to resources Recommend Favorite

Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice

By Innes Helen  

Supportive Care in Cancer, Vol. 16, Iss. 5, 2008-05 ,pp. : 485-491

Springer Publishing Company

Access to resources Recommend Favorite